| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 5.813 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 34 | 29.000 | 20141118, Santiago HD
| | 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 30 | 6.700 | 20141118, Santiago HD
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 2.470 | 20100301, Scala E
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 3.000 | 20140625, Armentia A
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 2.080 | 20120528, Patelis A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2005 | Austria | IgE | 11 | 45.500 | 20050102, Hantusch B
| | 1.4 - Respiratory Symptoms, Diagnosed | 2013 | Spain | IgE | 187 | 1.600 | 20131016, Feliu A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2005 | Austria | IgE | 12 | 16.700 | 20050102, Hantusch B
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.000 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 5.000 | 20091005, Ott H
| | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 4.300 | 20140606, Panzner P
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 6.000 | 20140625, Armentia A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 749 | 7.400 | 2003, Mari A
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Italy | IgE | 77 | 7.800 | 2002, Tinghino R
| | 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 25 | 8.000 | 2003a, Westritschnig K
| | 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 57 | 5.300 | 20041224, Moverare R
| | 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 12 | 0.000 | 20041224, Moverare R
| | 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 25 | 0.000 | 2003a, Westritschnig K
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2008 | Spain | IgE | 50 | 12.000 | 20080413, Luengo O
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2002 | France | IgE | 34 | 5.900 | 2002b, Niederberger V
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2002 | France | IgE | 32 | 9.000 | 2002b, Niederberger V
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2013 | Italy | IgE | 18 | 0.000 | 20131031, Bonura A
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2013 | Austria | IgE | 8 | 100.000 | 20130424, Garmatiuk T
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 10.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2008 | Italy | IgE | 246 | 13.000 | 20080613, Wopfner N
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2013 | Slovenia | IgE | 37 | 0.000 | 20131106, Homsak M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 32 | 6.000 | 20090211, Constantin C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 22 | 13.500 | 20090211, Constantin C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 8.108 | 20090826, Ebo DG
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2005 | Italy | IgE | 220 | 19.900 | 20050923, Rossi RE
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 8.000 | 20141003, Beitia JM
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2013 | Spain | IgE | 175 | 6.800 | 20130807, Letran A
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 43 | 11.600 | 20110713, Cabrera-Freitag P
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | Czech Republic | IgE | 48 | 12.500 | 20120424, Sekerkova A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2012 | Czech Republic | IgE | 82 | 17.100 | 20120424, Sekerkova A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2014 | Spain | IgE | 43 | 13.950 | 20140618, Cases B
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 3.030 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 101 | 1.980 | 20140306, Darsow U
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 0.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 0.000 | 20140127, Konradsen JR
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 6.100 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 4.000 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 4.000 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 17 | 29.000 | 20090211, Constantin C
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1999 | Austria | IgE | 102 | 9.800 | 1999, Niederberger V
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A
|
|
Loading...
Phl p 7
